NCT03564327Completed
Clinical Prognosis of Patients With Atrial Fibrillation During Radiofrequency Ablation
Clinical Prognosis of Patients With Atrial Fibrillation During Radiofrequency Ablation and Interest of the Isochron Map
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
Identify the parameters of the predictive isochronous map for the clinical outcome of radiofrequency ablation in terms of absence of documented atrial fibrillation recurrence at 18 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 175 (actual)
- First submitted
- 11 Jun 2018
- Start date
- 14 Feb 2019
- Primary completion date
- 9 Feb 2023
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Diseases
- Atrial fibrillation
- NCT number
- NCT03564327
What you commit to
- Study type: Interventional
- Participants enrolled: 175
- From 14 Feb 2019 to the primary completion date, 9 Feb 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
Other
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- The patient is pregnant or breastfeeding Early Study Exit Criteria: Patient does not have paroxysmal or persistent AF at the time of inclusion
Who the study is looking for
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
- The patient is at least 18 years old
- The patient is available for 18 month follow-up
- The patient has paroxysmal or persistent atrial fibrillation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| CHU Nîmes Coordinator of this site? Confirm its status | Nîmes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.